✦ LIBER ✦

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents

✍ Scribed by Pär Svanborg; Gunilla Thernlund; Per A. Gustafsson; Bruno Hägglöf; Alexander Schacht; Björn Kadesjö

Publisher: Springer
Year: 2009
Tongue: English
Weight: 221 KB
Volume: 18
Category: Article
ISSN: 1018-8827
DOI: 10.1007/s00787-009-0031-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atomoxetine in children and adolescents

Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia

✍ Ferenc Martenyi; Nikolay N. Zavadenko; Natalia B. Jarkova; Alexandr A. Yarosh; V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 245 KB

Amantadine versus methylphenidate in chi

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial

✍ Mohammad-Reza Mohammadi; Mohammad-Reza Kazemi; Ebtehal Zia; Shams-Ali Rezazadeh; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Objective The aim of the present study was to further evaluate, under double blind and controlled conditions, the efficacy of amantadine for attention‐deficit/hyperactivity disorder (ADHD) in children and adolescents as compared to methylphenidate. Methods This was a 6‐week randomized

Effect of atomoxetine on quality of life

Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder

✍ Peter M. Wehmeier; Alexander Schacht; Ralf W. Dittmann; Karin Helsberg; Christia 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 324 KB

Efficacy and safety of the novel α4β2neu

Efficacy and safety of the novel α4β2neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

✍ George Apostol; Walid Abi-Saab; Christopher J. Kratochvil; Lenard A. Adler; Wein 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 321 KB

Efficacy and tolerability of duloxetine

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo